pharmanewsdaily
1509 posts
Eiger BioPharmaceuticals doses first patients with Lambda in COVID-19 trial
Eiger BioPharmaceuticals said that it has dosed the first patients in a phase 2 trial of its hepatitis…
May 1, 2020
Trio Pharmaceuticals, Aji Bio-Pharma to co-develop antibody drug conjugates
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) have entered into a development collaboration agreement to assess AJICAP,…
May 1, 2020
Verndari begins preclinical testing of COVID-19 vaccine candidate
Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered…
April 30, 2020
CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials
US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development…
April 29, 2020
Citius seeks FDA nod for evaluating stem cell therapy for ARDS in COVID-19
Citius Pharmaceuticals has made a Pre-IND submission to the US Food and Drug Administration for a novel stem…
April 28, 2020
Innovent Biologics begins parsaclisib phase 2 trial in follicular lymphoma
Innovent Biologics has dosed the first patient in a phase 2 trial of parsaclisib (IBI-376), a novel and…
April 28, 2020
COVID-19 RT-PCR detection kit : Fosun Pharma secures FDA EUA status
Shanghai Fosun Pharmaceutical (Fosun Pharma) has been granted the emergency use authorization (EUA) status for its COVID-19 RT-PCR detection…
April 27, 2020
GS COVID-19RT-PCR diagnostic test : GenoSensor secures FDA EUA status
COVID-19 diagnostic test : GenoSensor has been granted emergency use authorization status from the US Food and Drug…
April 26, 2020
Takeda Pharmaceutical to sell OTC and non-core products to Orifarm
Japan-based Takeda Pharmaceutical has agreed to sell a portfolio of 110 non-core over-the-counter (OTC) and prescription pharmaceutical products…
April 25, 2020
SARS-CoV-2 vaccine trial : Sinovac Biotec begins COVID-19 vaccine candidate human trial
SARS-CoV-2 vaccine trial : Chinese biopharma company Sinovac Biotech has started a phase 1 clinical trial for SARS-CoV-2…
April 25, 2020